AL
INO icon

Airain Ltd’s Inovio Pharmaceuticals INO Stock Holding History

Airain Ltd’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,680
Closed -$140K – 892
2016
Q4 		$140K Buy
1,680
+540
+47% +$48.8K 0.01% 623
2016
Q3 		$128K Buy
+1,140
New +$126K 0.01% 560
2016
Q1 		– Sell
-6,272
Closed -$506K – 928
2015
Q4 		$506K Sell
6,272
-3,293
-34% -$262K 0.03% 458
2015
Q3 		$663K Buy
+9,565
New +$833K 0.04% 414
2015
Q1 		– Sell
-1,262
Closed -$139K – 896
2014
Q4 		$139K Buy
+1,262
New +$154K 0.01% 631

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Airain Ltd's INO Position: Q1 2017 in Review

Airain Ltd sold out of Inovio Pharmaceuticals (INO) in Q1 2017, closing a stake of 1,680 shares — an estimated $140K sold.

Airain Ltd first reported a position in INO in Q4 2014 and held it in 5 quarters. The position peaked at $663K in Q3 2015. 106 funds tracked by Wall St. Rank hold INO as of Q1 2017.

  • Airain Ltd reported no remaining Inovio Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Airain Ltd sold 1,680 Inovio Pharmaceuticals shares in Q1 2017, an estimated $140K.
  • Airain Ltd first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Airain Ltd's Inovio Pharmaceuticals position peaked at $663K in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2017.

Based on Airain Ltd's 13F filing for Q1 2017, filed 9 May 2017.